The SEC emphasized ADM’s cooperation in resolving the matter.
The SEC emphasized ADM’s cooperation in resolving the matter.
The company failed to properly inform investors about regulatory challenges it was experiencing with the FDA.
Two former executives were fined, but the company itself will not receive a civil penalty due to its self-reporting.
The four settlements come nearly one year after the SEC sued SolarWinds for misleading investors about its cybersecurity controls.
In this week’s roundup, we see a mix of charges, including disclosure failings within a donor data management software company.